FDA 采用真实世界证据作为主要或唯一证据支持医疗器械上市注册的产品特征分析

China Food Drug Administration ›› 2024, Vol. 0 ›› Issue (10) : 68-75.

PDF(1596 KB)
PDF(1596 KB)
China Food Drug Administration ›› 2024, Vol. 0 ›› Issue (10) : 68-75. DOI: 10.3969/j.issn.1673-5390.2024.10.008

Author information +
History +

Cite this article

Download Citations
PDF(1596 KB)

136

Accesses

0

Citation

Detail

Sections
Recommended

/